1) LL-37 / hCAP-18
LL-37/hCAP-18
1.
Objective To construct a eukaryotic expression vector for LL-37 / hCAP-18(18 kD human cationic antimicrobial peptide)and express in human breast cancer MCF-7 cells.
目的构建人源抗菌肽LL-37/hCAP-18的真核表达载体,并在人乳腺癌细胞MCF-7中进行表达。
2) reconstructed LL-37
LL-37改建
3) antimicrobial peptide LL-37
抗菌肽LL-37
1.
Modification of 5′-UTR sequences of pPIC9 increases expression of antimicrobial peptide LL-37;
5′-非转录区序列改建提高毕赤酵母表达抗菌肽LL-37
2.
The mRNA expression of antimicrobial peptide LL-37 and human beta defensin-2 in the patients with psoriasis vulgaris;
寻常性银屑病患者皮损中抗菌肽LL-37和人β防御素-2mRNA的表达
4) LL-37/hCAP-18
LL-37hCAP-18
5) human cathelicidin LL-37
人源杀菌肽LL-37
1.
Objective To reconstruct the proteinic sequence of human cathelicidin LL-37 to increase the bactericidal activity of LL-37 and to express the reconstructed LL-37 (rLL-37) in bacterium.
目的改良人源杀菌肽LL-37的氨基酸序列,提高其杀菌力,并在原核细菌中表达。
6) human antimicrobial peptide LL-37
人源抗菌肽LL-37
1.
To make highly expressed human antimicrobial peptide LL-37 in prokaryotic expression system,the part of codon of LL-37 was replaced and a new LL-37 series was designed in this work.
为了使人源抗菌肽LL-37在原核表达载体中获得高效表达,在不改变LL-37氨基酸的基础上,根据大肠杆菌偏爱密码子表,替换LL-37部分密码子,设计一段新的LL-37序列。
补充资料：indium ll3Inm penteyonate injection
分子式：
CAS号：
性质：又称铟113m二亚乙基三胺无亚甲基膦酸(indium 113Inm diethylenetriamine pentamet-hylenophosphonic acid注射液；113Inm-DTPP)注射液。在无菌操作条件下，氯化铟113m注射液与泮替膦酸注射液反应，得到的无色澄明放射性诊断用药，主要用于骨显像。
CAS号：
性质：又称铟113m二亚乙基三胺无亚甲基膦酸(indium 113Inm diethylenetriamine pentamet-hylenophosphonic acid注射液；113Inm-DTPP)注射液。在无菌操作条件下，氯化铟113m注射液与泮替膦酸注射液反应，得到的无色澄明放射性诊断用药，主要用于骨显像。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条